Capricor Therapeutics
CAPR
#7980
Rank
HK$2.26 B
Marketcap
HK$49.49
Share price
-4.36%
Change (1 day)
-57.79%
Change (1 year)

Market capitalization of Capricor Therapeutics (CAPR)

Market cap: HK$2.26 Billion

As of December 2025 Capricor Therapeutics has a market cap of HK$2.26 Billion. This makes Capricor Therapeutics the world's 7980th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Capricor Therapeutics from 2002 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$2.26 B-54.48%
2024HK$4.97 B322.64%
2023HK$1.17 B54.48%
2022HK$0.76 B37.98%
2021HK$0.55 B1.48%
2020HK$0.54 B943.35%
2019HK$52.11 M-48.29%
2018HK$0.10 B-68.25%
2017HK$0.31 B-28.1%
2016HK$0.44 B13.99%
2015HK$0.38 B13.72%
2014HK$0.34 B15.61%
2013HK$0.29 B1712.04%
2012HK$16.25 M-90.33%
2011HK$0.16 B0.6%
2010HK$0.16 B-34.25%
2009HK$0.25 B60.2%
2008HK$0.15 B-84.65%
2007HK$1.03 B4299.99%
2006HK$23.48 M-38.27%
2005HK$38.04 M-0.23%
2004HK$38.13 M27.78%
2003HK$29.84 M-63.79%
2002HK$82.43 M

End of Day market cap according to different sources

On Dec 9th, 2025 the market cap of Capricor Therapeutics was reported to be:

HK$11.01 Billion
by Nasdaq info icon info icon
HK$2.26 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Cytokinetics
CYTK
HK$57.86 B 2,457.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
HK$0.37 B-83.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$3.816 T 168,593.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$118.13 B 5,121.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
HK$14.46 B 539.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
HK$80 M-96.46%๐Ÿ‡บ๐Ÿ‡ธ USA